Navamedic ASA: Releases SippLink™ for MetaVision, one of Europe’s leading electronic patient journal systems

16.10.2018 08:36:31

Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, announced today that it has released its wireless connectivity solution, SippLink™ for iMDsoft’s patient data monitoring system (PDMS), MetaVision. The release follows successful validation at Uppsala University Hospital in Sweden, and represents the market’s first wireless PDMS-connected digital urinometer.

SippLink enables wireless transfer of data between the Sippi urine measuring system and an external patient data monitoring systems (PDMS). Following successful validation at the University Hospital of Uppsala in Sweden, SippLink for the PDMS MetaVision has now been released to the market. MetaVision is one of the leading PDMS vendors in Europe with clients in Norway, Sweden and all major EU countries. This is the second electronic patient journal system that now is compatible with SippLink. Sippi is the market’s only digital urine measurement system supporting wireless data transfer to these systems.

“We are very happy to announce the release of SippLink for MetaVision following successful clinical validation at Uppsala University Hospital. This marks a milestone in our roll-out of Sippi to the increasing number of clinics equipped with PDMS, including all major hospitals and university hospitals. Being able to offer connectivity to Sippi is also a major step for our sales development across Europe, as Sippi is the only system on the market that can close the final gap for a fully digitalized intensive care unit, including digital urine measurement,” says Magnus Emmoth, CEO of Navamedic Medtech.

Sippi is a new standard for urine monitoring which enables automated digital measurement. The Sippi® system represents a new and improved way of monitoring urine output, the last manual and non-digitalized viral parameter within the Intensive Care Unit (ICU).

For further information, please contact:

Tom Rönnlund, CEO, Navamedic ASA, Tel: +46 727 320 321

Magnus Emmoth, CEO, Navamedic Medtech AB, Tel: +46 704 12 11 97

About Navamedic ASA

Navamedic ASA is a Norwegian medtech and pharmaceutical products company, delivering products to patients, hospitals and pharmacies in the Nordic and Benelux markets. The Group's Medtech business has developed and is currently introducing the next generation of digital urine meter Sippi®. Navamedic's Pharma and Healthcare business is a distributor of products supplied by a number of pharmaceutical manufacturers. Navamedic is listed on the Oslo Stock Exchange (ticker: NAVA).